Actos - Market Research and Reports

Actos, produced by Takeda Pharmaceuticals North America, Inc netted $2.5m in sales in 2009, the 9th highest in the world.

Actos is a type of thiazolidinediones, acting to increase sensitivity to Insulin. This sensitivity is lost in Type II Diabetes, the disease which Actos is prescribed for. Diabetes (Type II) is becoming increasingly common in the developed world, and may explain the high sales value of this drug. 

Source; Adapted from BioPortfolio.com and Actos.com

BioPortfolio's Easy Ordering System

  1. Search for the report you need from our store
  2. Make online payment with our easy checkout process
  3. Receive PDF report via email

Easy Online Payment or Pro Forma Invoice

We accept the following credit cards...



or can supply a pro-forma invoice if required.

Related Reports:

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data
{STICKYFOOTERMOBILE}